Overview
US and INJ rarely move in perfect sync. Today’s print ($1,882.43/$5.13) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | US | INJ |
|---|---|---|
| Price | $1,882.43 | $5.13 |
| Market Cap | $550.45M | $490.41M |
| FDV | — | — |
| Volume 24h | $9.26M | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 184.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | US | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -3.80% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | US | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (58.20 vs 48.70) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | US | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
US
Injective
Pros and cons
Pros of US
- Higher ranking for US can translate into tighter spreads on major venues.
- US has an established coin page footprint on PEPS for continuous monitoring.
- Market-cap scale on US may dampen some idiosyncratic shocks versus smaller peers.
Cons of US
- Large-cap status for US can mean slower percentage upside versus high-beta alternatives.
- When dominance narratives fade, US can lag hotter rotation names.
- Crowded positioning around US sometimes amplifies squeeze or flush risk.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Injective can offer higher relative beta when market attention rotates toward its niche.
Cons of Injective
- Trend failures on Injective often travel faster than on more established assets.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
If you weight capitalization and liquidity, US looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
For readers asking which is “better”, the honest answer is conditional. US and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, US or Injective?
“Better” depends on horizon and risk. US leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, US or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both US and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. US currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.